Robert J. Kammer, Director at Imprimis Pharmaceuticals, Inc. (IMMY), sold 10,000 shares at $4.21 ($42K) on 2018-11-01, disclosed to the SEC on 2018-11-02.
Scheduled sale ($42k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HROW | SELL | 2019-09-11 | $37K | — | Filing → |
| HROW | SELL | 2019-08-14 | $45K | — | Filing → |
| HROW | SELL | 2019-07-16 | $51K | — | Filing → |